245 related articles for article (PubMed ID: 25956075)
21. The abbreviated impactor measurement (AIM) concept: part II--Influence of evaporation of a volatile component-evaluation with a "droplet-producing" pressurized metered dose inhaler (pMDI)-based formulation containing ethanol as cosolvent.
Mitchell JP; Nagel MW; Avvakoumova V; MacKay H; Ali R
AAPS PharmSciTech; 2009; 10(1):252-7. PubMed ID: 19291411
[TBL] [Abstract][Full Text] [Related]
22. Insulin nanoparticles: stability and aerosolization from pressurized metered dose inhalers.
Nyambura BK; Kellaway IW; Taylor KM
Int J Pharm; 2009 Jun; 375(1-2):114-22. PubMed ID: 19481697
[TBL] [Abstract][Full Text] [Related]
23. [Progress of research on pressurized metered dose inhalers].
Zhou X
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):213-5. PubMed ID: 23856147
[No Abstract] [Full Text] [Related]
24. Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler.
Biswas R; Hanania NA; Sabharwal A
J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):256-266. PubMed ID: 28157430
[TBL] [Abstract][Full Text] [Related]
25. Humidity affects the morphology of particles emitted from beclomethasone dipropionate pressurized metered dose inhalers.
Ivey JW; Bhambri P; Church TK; Lewis DA; McDermott MT; Elbayomy S; Finlay WH; Vehring R
Int J Pharm; 2017 Mar; 520(1-2):207-215. PubMed ID: 28167262
[TBL] [Abstract][Full Text] [Related]
26. The Evolution of Pressurized Metered-Dose Inhalers from Early to Modern Devices.
Roche N; Dekhuijzen PN
J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):311-27. PubMed ID: 26824873
[TBL] [Abstract][Full Text] [Related]
27. Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers.
Chierici V; Cavalieri L; Piraino A; Paleari D; Quarta E; Sonvico F; Melani AS; Buttini F
Expert Opin Drug Deliv; 2020 Jul; 17(7):1025-1039. PubMed ID: 32551990
[TBL] [Abstract][Full Text] [Related]
28. Reverse aqueous microemulsions in hydrofluoroalkane propellants and their aerosol characteristics.
Selvam P; Bharatwaj B; Porcar L; da Rocha SR
Int J Pharm; 2012 Jan; 422(1-2):428-35. PubMed ID: 22044539
[TBL] [Abstract][Full Text] [Related]
29. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers.
Smyth HD; Hickey AJ
AAPS PharmSciTech; 2003; 4(3):E38. PubMed ID: 14621970
[TBL] [Abstract][Full Text] [Related]
30. Investigations into the formulation of metered dose inhalers of salmeterol xinafoate and fluticasone propionate microcrystals.
Murnane D; Martin GP; Marriott C
Pharm Res; 2008 Oct; 25(10):2283-91. PubMed ID: 18509598
[TBL] [Abstract][Full Text] [Related]
31. Effects of Formulation Variables on Lung Dosimetry of Albuterol Sulfate Suspension and Beclomethasone Dipropionate Solution Metered Dose Inhalers.
Schroeter JD; Sheth P; Hickey AJ; Asgharian B; Price OT; Holt JT; Conti DS; Saluja B
AAPS PharmSciTech; 2018 Jul; 19(5):2335-2345. PubMed ID: 29858973
[TBL] [Abstract][Full Text] [Related]
32. Variability in Delivered Dose from Pressurized Metered-Dose Inhaler Formulations Due to a Delay Between Shake and Fire.
Hatley RH; Parker J; Pritchard JN; von Hollen D
J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):71-79. PubMed ID: 27635793
[TBL] [Abstract][Full Text] [Related]
33. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
[TBL] [Abstract][Full Text] [Related]
34. Flow Structure and Particle Deposition Analyses for Optimization of a Pressurized Metered Dose Inhaler (pMDI) in a Model of Tracheobronchial Airway.
Ahookhosh K; Saidi M; Mohammadpourfard M; Aminfar H; Hamishehkar H; Farnoud A; Schmid O
Eur J Pharm Sci; 2021 Sep; 164():105911. PubMed ID: 34129919
[TBL] [Abstract][Full Text] [Related]
35. Lung deposition of 99mTc-radiolabeled albuterol delivered through a pressurized metered dose inhaler and spacer with facemask or mouthpiece in children with asthma.
Ditcham W; Murdzoska J; Zhang G; Roller C; von Hollen D; Nikander K; Devadason SG
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S63-75. PubMed ID: 25054483
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
[TBL] [Abstract][Full Text] [Related]
37. Particle synergy and aerosol performance in non-aqueous liquid of two combinations metered dose inhalation formulations: an AFM and Raman investigation.
Rogueda PG; Price R; Smith T; Young PM; Traini D
J Colloid Interface Sci; 2011 Sep; 361(2):649-55. PubMed ID: 21714970
[TBL] [Abstract][Full Text] [Related]
38. Delay Between Shaking and Actuation of a Hydrofluoroalkane Fluticasone Pressurized Metered-Dose Inhaler.
Berlinski A; von Hollen D; Pritchard JN; Hatley RH
Respir Care; 2018 Mar; 63(3):289-293. PubMed ID: 29162718
[TBL] [Abstract][Full Text] [Related]
39. Influence of the valve lubricant on the aerodynamic particle size of a metered dose inhaler.
Berry J; Kline L; Naini V; Chaudhry S; Hart J; Sequeira J
Drug Dev Ind Pharm; 2004 Mar; 30(3):267-75. PubMed ID: 15109026
[TBL] [Abstract][Full Text] [Related]
40. Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseases.
Ferguson GT; Hickey AJ; Dwivedi S
Respir Med; 2018 Jan; 134():16-23. PubMed ID: 29413503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]